GlassScriptPhysician profile
Rebecca Smith
NPI 1083684583
$6,926.90
in general payments reported to CMS, 2019-2025
24 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,746 · 2020: $434 · 2021: $673 · 2022: $446 · 2023: $323 · 2024: $835 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.70 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,171.17 | 2019-2024 | Mitraclip, Navitor, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $1,588.39 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $805.16 | 2019-2021 | |
| Amgen INC. | $421.12 | 2019-2020 | |
| Boston Scientific Corporation | $383.25 | 2019-2024 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $381.19 | 2019-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $301.05 | 2019-2021 | |
| Pfizer INC. | $173.23 | 2019-2020 | |
| Integra Lifesciences Corporation | $144.67 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Janssen Biotech, INC. | $94.99 | 2025 | Tremfya |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.01 | 2019 | |
| Biosense Webster, INC. | $70.79 | 2025 | Soundstar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.89 | 2019 | |
| Lundbeck LLC | $41.61 | 2019 | |
| Medtronic Vascular, INC. | $40.41 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $32.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.85 | 2025 | |
| Esperion Therapeutics, INC. | $18.82 | 2024 | Nexletol |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.80 | 2023 | Arazlo |
| Kowa Pharmaceuticals America, INC. | $15.25 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $14.63 | 2019 | |
| Amarin Pharma, INC. | $12.73 | 2020 | |
| Leo Pharma INC. | $12.64 | 2020 | |
| Amryt Pharma Holdings LTD | $12.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.